InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Thursday, 03/14/2019 3:10:42 PM

Thursday, March 14, 2019 3:10:42 PM

Post# of 504
News: $INFI Infinity To Initiate MARIO-3, A Phase 2 Multi-Arm Study Evaluating IPI-549 In Front-Line Triple Negative Breast Cancer And Renal Cell Cancer

CAMBRIDGE, Mass. , March 14, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that it has entered into a master clinical supply agreement under which Roche will supply atezolizumab (Tecentriq ® ) to Infinity for use in MARIO-3, a Phase ...

Read the whole news https://marketwirenews.com/news-releases/infinity-to-initiate-mario-3-a-phase-2-multi-arm-study-evaluating-ipi-549-in-front-line-triple-negative-breast-cancer-and-renal-cell-cancer-7846680.html